Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement

Sponsor
Thomas Jefferson University (Other)
Overall Status
Completed
CT.gov ID
NCT03243942
Collaborator
American Heart Association (Other), Lantheus Medical Imaging (Industry)
56
1
1
24.8
2.3

Study Details

Study Description

Brief Summary

The fundamental hypothesis of this project is that real-time intracardiac pressures can be monitored and quantified noninvasively in humans using a novel contrast-enhanced ultrasound technique called subharmonic-aided pressure estimation (SHAPE).This study will use contrast echocardiography to assess the accuracy of SHAPE compared to simultaneously acquired intracardiac pressures measured invasively during cardiac catheterization. This study is designed to verify that contrast echocardiography using the SHAPE method, already proven in a canine model and tested in a human pilot study can be used as a surrogate for cardiac catheterization with sufficient accuracy to allow clinical applicability in humans.

Condition or Disease Intervention/Treatment Phase
Phase 2

Study Design

Study Type:
Interventional
Actual Enrollment :
56 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement
Actual Study Start Date :
Jun 1, 2017
Actual Primary Completion Date :
Jun 26, 2019
Actual Study Completion Date :
Jun 26, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Definity for pressure measurements

2 vials of activated Definity mixed with 50 ml saline. As per manufacturer's recommendation the infusion rate may vary between 4-10 ml/min (to provide diagnostic intracardiac contrast visibility).

Drug: Definity
Whenever a patient undergoes cardiac catheterization, which routinely includes intracardiac pressure monitoring using a pressure catheter, as part of their standard clinical care and agrees to participate in the study, we will acquire research data. With Definity infusion, SHAPE algorithm will be initiated to determine optimum acoustic pressure. Then, at the optimum acoustic pressure SHAPE specific data will be acquired from the cardiac chambers and aorta synchronously with the pressures recorded by the catheter (as a part of the patient's standard of care). After acquiring the ultrasound imaging data, the remainder of the heart catheterization will be completed by the attending cardiologist according to the patients' standard of care.

Outcome Measures

Primary Outcome Measures

  1. Agreement between SHAPE and pressure catheter measurements [up to 1 day]

    Correlation

  2. Error between SHAPE and pressure catheter measurements [up to 1 day]

    ANOVA/Post-hoc comparisons

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Be scheduled for a cardiac catheterization procedure

  • Adult patients over the age of 21

  • Acceptable baseline echocardiographic images in the supine position

  • If a female of child-bearing potential, must have a negative pregnancy test

  • Provide written informed consent

Exclusion Criteria:
  • Clinically unstable patients, e.g., those who are clinically in decompensated heart failure or having active chest pain or presenting for admission with an unstable anginal syndrome

  • Patients in whom introduction of a catheter into the left ventricle is contraindicated or would potentially be dangerous, e.g., patients with active ventricular arrhythmias or with significant aortic valve stenosis where crossing the aortic valve may be difficult and not clinically necessary

  • Patients with anatomic right-to-left, bi-directional, or transient right-to-left cardiac shunts where Definity could traverse as a bolus

  • Patients with known hypersensitivity to Definity

  • Females who are pregnant or nursing

Contacts and Locations

Locations

Site City State Country Postal Code
1 Thomas Jefferson University and Thomas Jefferson University Hospital Philadelphia Pennsylvania United States 19107

Sponsors and Collaborators

  • Thomas Jefferson University
  • American Heart Association
  • Lantheus Medical Imaging

Investigators

  • Principal Investigator: Jaydev Dave, Thomas Jefferson University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jaydev Dave, Assistant Professor, Thomas Jefferson University
ClinicalTrials.gov Identifier:
NCT03243942
Other Study ID Numbers:
  • 15SDG25740015
First Posted:
Aug 9, 2017
Last Update Posted:
Jul 10, 2019
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Jaydev Dave, Assistant Professor, Thomas Jefferson University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 10, 2019